Condition
Neurofibroma, Plexiform clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Neurofibroma, Plexiform clinical trials that are recruiting, at sites in 4 countries (most in South Korea (3), United States (3), Australia (2)). By phase: Phase 1 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Neurofibroma, Plexiform clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Testing PAS-004 for adults with Neurofibromatosis Type 1 and plexiform neurofibromas | Phase 1 | Birmingham, Alabama and 4 other locations | Recruiting | May 8, 2025 |
| Testing PAS-004 for adults with Neurofibromatosis Type 1 and plexiform neurofibromas | Phase 1 | Birmingham, Alabama and 4 other locations | Recruiting | May 8, 2025 |
| Study on the use of Koselugo for treating Neurofibromatosis 1 | — | Busan and 11 other locations | Recruiting | Apr 11, 2024 |
| Using cryotherapy to treat neurofibromas in patients with Neurofibromatosis Type 1 | — | Lyon | Recruiting | Jan 20, 2022 |
| Testing TURALIO(R) for treating hard-to-treat cancers in young people | Phase 1 | Bethesda, Maryland | Recruiting | Mar 18, 2015 |
All recruiting trials (5)
-
Testing PAS-004 for adults with Neurofibromatosis Type 1 and plexiform neurofibromas
This study is testing a new medication called PAS-004 to see if it is safe and helps adults with Neurofibromatosis Type 1 and painful plexiform neurofibromas.
-
Testing PAS-004 for adults with Neurofibromatosis Type 1 and plexiform neurofibromas
This study is testing a new medication called PAS-004 to see if it is safe and helps adults with Neurofibromatosis Type 1 and painful plexiform neurofibromas.
-
Study on the use of Koselugo for treating Neurofibromatosis 1
This study is testing how well Koselugo works and how safe it is for people with Neurofibromatosis 1 in everyday treatment settings in South Korea.
-
Using cryotherapy to treat neurofibromas in patients with Neurofibromatosis Type 1
This study is testing if using extreme cold to treat tough tumors can help people with Neurofibromatosis Type 1 feel better without needing surgery.
-
Testing TURALIO(R) for treating hard-to-treat cancers in young people
This study is testing if TURALIO(R) can safely help children and young adults with tough-to-treat cancers by seeing how well it works to shrink tumors or stop them from growing.
Related topics
Quick answers
How many Neurofibroma, Plexiform clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in South Korea (3 trials), United States (3 trials), Australia (2 trials), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.